Endo International plc (ENDP) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
MINERVA HOUSE, SIMMONSCOURT ROAD DUBLIN 4, 00000 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,019 | 1,507 | 1,213 | 1,455 | 1,149 | 987 | |||
| Cash and cash equivalents | 1,019 | 1,507 | 1,213 | 1,455 | 1,149 | 987 | |||
| Restricted cash and investments | 145 | 124 | 172 | 247 | 305 | 320 | |||
| Receivables | 501 | 599 | 575 | 516 | 510 | 529 | |||
| Inventory, net of allowances, customer advances and progress billings | 274 | 284 | 352 | 328 | 322 | 391 | |||
| Inventory | 274 | 284 | 352 | 328 | 322 | 391 | |||
| Contract with customer, asset, after allowance for credit loss | 2 | 3 | 3 | 9 | ✕ | ||||
| Other undisclosed current assets | 135 | 198 | 98 | 41 | 47 | 43 | |||
| Total current assets: | 2,077 | 2,715 | 2,413 | 2,586 | 2,343 | 2,271 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 23 | 11 | 13 | ||||||
| Finance lease, right-of-use asset, after accumulated amortization | 27 | 38 | 48 | ✕ | ✕ | ||||
| Operating lease, right-of-use asset | 28 | 35 | 37 | 52 | ✕ | ✕ | |||
| Property, plant and equipment | 505 | 499 | 524 | ||||||
| Long-term investments and receivables | 1 | 1 | |||||||
| Long-term investments | 1 | 1 | |||||||
| Intangible assets, net (including goodwill) | 3,085 | 5,560 | 6,301 | 6,166 | 7,222 | 8,768 | |||
| Goodwill | 1,352 | 3,197 | 3,560 | 3,595 | 3,765 | 4,450 | |||
| Intangible assets, net (excluding goodwill) | 1,733 | 2,363 | 2,741 | 2,571 | 3,457 | 4,318 | |||
| Restricted cash and investments | 85 | ||||||||
| Deferred income tax assets | 1 | 2 | 2 | ✕ | ✕ | ||||
| Other noncurrent assets | 130 | 60 | 53 | 78 | 67 | 60 | |||
| Other undisclosed noncurrent assets | 304 | 348 | 398 | 1 | 12 | ||||
| Total noncurrent assets: | 3,681 | 6,053 | 6,851 | 6,803 | 7,789 | 9,365 | |||
| TOTAL ASSETS: | 5,758 | 8,767 | 9,265 | 9,390 | 10,132 | 11,636 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 687 | 837 | 836 | 900 | 1,009 | 1,097 | |||
| Interest and dividends payable | ✕ | ✕ | 107 | 98 | 113 | 130 | |||
| Taxes payable | ✕ | ✕ | 1 | 2 | 2 | 2 | |||
| Employee-related liabilities | ✕ | ✕ | 90 | 130 | 80 | 90 | |||
| Accounts payable | 109 | 123 | 94 | 102 | 96 | ||||
| Accrued liabilities | 220 | 115 | 108 | 146 | 150 | 1,097 | |||
| Other undisclosed accounts payable and accrued liabilities | 358 | 402 | 405 | 457 | 542 | (2) | |||
| Deferred revenue | 1 | 1 | 1 | 1 | ✕ | ✕ | |||
| Debt | 207 | 40 | 51 | 40 | 41 | ||||
| Business combination, contingent consideration, liability | 71 | ||||||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 2 | ✕ | ||
| Other undisclosed current liabilities | 2 | 585 | 376 | 508 | 899 | 1,013 | |||
| Total current liabilities: | 690 | 1,630 | 1,254 | 1,460 | 1,950 | 2,221 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1 | 8,083 | 8,319 | 8,408 | 8,258 | 8,279 | |||
| Long-term debt, excluding current maturities | 8,049 | 8,281 | 8,360 | 8,224 | 8,242 | ||||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | 34 | 37 | ||
| Finance lease, liability | 1 | ✕ | ✕ | ||||||
| Liabilities, other than long-term debt | 62 | 299 | 340 | 388 | 422 | 434 | |||
| Deferred income tax liabilities | 14 | 22 | 26 | 32 | ✕ | ✕ | |||
| Other liabilities | 43 | 277 | 314 | 356 | 422 | 434 | |||
| Operating lease, liability | 5 | 34 | 38 | 48 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 0 | 217 | |||||||
| Total noncurrent liabilities: | 63 | 8,381 | 8,659 | 8,796 | 8,681 | 8,930 | |||
| Total liabilities: | 753 | 10,011 | 9,913 | 10,256 | 10,631 | 11,151 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (4,162) | (1,244) | (648) | (867) | (498) | 485 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 8,969 | 8,954 | 8,938 | 8,905 | 8,856 | 8,791 | |||
| Accumulated other comprehensive loss | (227) | (216) | (218) | (219) | (229) | (210) | |||
| Accumulated deficit | (12,905) | (9,982) | (9,368) | (9,552) | (9,125) | (8,097) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | 0 | 0 | |||||
| Other undisclosed equity | 0 | 0 | |||||||
| Total equity: | (4,162) | (1,244) | (648) | (867) | (498) | 485 | |||
| Other undisclosed liabilities and equity | 9,167 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 5,758 | 8,767 | 9,265 | 9,390 | 10,132 | 11,636 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,319 | 2,993 | 2,903 | 2,914 | 2,947 | 3,469 | ||
| Cost of revenue | (1,092) | (1,221) | (1,443) | (1,569) | (1,632) | (2,229) | ||
| Gross profit: | 1,226 | 1,772 | 1,461 | 1,345 | 1,315 | 1,240 | ||
| Operating expenses | (3,961) | (2,215) | (1,478) | (1,867) | (1,785) | (2,200) | ||
| Operating loss: | (2,735) | (443) | (17) | (522) | (469) | (960) | ||
| Nonoperating income (expense) | 34 | 20 | 21 | (17) | 52 | 17 | ||
| Gain (loss), foreign currency transaction, before tax | 2 | (1) | (2) | (5) | 4 | |||
| Other nonoperating income (expense) | 6 | 17 | 5 | (15) | 6 | 17 | ||
| Interest and debt expense | (350) | (576) | (533) | 118 | (52) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (522) | (488) | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (3,051) | (999) | (529) | (421) | (939) | (1,483) | ||
| Income (loss) from equity method investments | (0) | (0) | 2 | (2) | ||||
| Other undisclosed income (loss) from continuing operations before income taxes | 163 | 453 | 500 | 78 | ||||
| Loss from continuing operations before income taxes: | (2,888) | (547) | (27) | (345) | (939) | (1,483) | ||
| Income tax expense (benefit) | (22) | (22) | 274 | (16) | (23) | 250 | ||
| Income (loss) from continuing operations: | (2,910) | (569) | 247 | (361) | (962) | (1,233) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (569) | 247 | (361) | (1,031) | (2,035) | ||
| Loss from discontinued operations | (70) | (803) | ||||||
| Other undisclosed net loss | (44) | (64) | (62) | |||||
| Net income (loss): | (2,910) | (613) | 184 | (423) | (1,031) | (2,035) | ||
| Other undisclosed net loss attributable to parent | (13) | |||||||
| Net income (loss) available to common stockholders, diluted: | (2,923) | (613) | 184 | (423) | (1,031) | (2,035) | ||
Comprehensive Income ($ in millions)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,910) | (613) | 184 | (423) | (1,031) | (2,035) | ||
| Other comprehensive income (loss) | (19) | 144 | ||||||
| Comprehensive income (loss): | (2,910) | (613) | 184 | (423) | (1,051) | (1,892) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (24) | 1 | 1 | 10 | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | (2,934) | (612) | 185 | (412) | (1,051) | (1,892) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.